Evaluation of antibody responses in patients with b-cell malignancies after two and three doses of anti-sars-cov-2 s vaccination—a retrospective cohort study

HIGHLIGHTS

• who: Stella Rosa Maria Wirth and colleagues from the Karl Landsteiner University of Health Sciences, DrKarl-Dorrek-Strau00dfe, Krems, Austria have published the article: Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccinationu2014A Retrospective Cohort Study, in the Journal: Cancers 2023, 524 of /2023/
• what: The aim of this study was to determine standardized anti-SARS-CoV-2 S antibody levels and to evaluate differences between treatment modalities in response to the second and third vaccines among patients with B-cell malignancies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.